rs756859126
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000352480.10(ASS1):c.1069C>T(p.Gln357Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000352480.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASS1 | NM_054012.4 | c.1069C>T | p.Gln357Ter | stop_gained | 13/15 | ENST00000352480.10 | NP_446464.1 | |
ASS1 | NM_000050.4 | c.1069C>T | p.Gln357Ter | stop_gained | 14/16 | NP_000041.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASS1 | ENST00000352480.10 | c.1069C>T | p.Gln357Ter | stop_gained | 13/15 | 1 | NM_054012.4 | ENSP00000253004 | P1 | |
ASS1 | ENST00000372393.7 | c.1069C>T | p.Gln357Ter | stop_gained | 14/16 | 5 | ENSP00000361469 | P1 | ||
ASS1 | ENST00000372394.5 | c.1069C>T | p.Gln357Ter | stop_gained | 14/16 | 2 | ENSP00000361471 | P1 | ||
ASS1 | ENST00000372386.6 | n.340C>T | non_coding_transcript_exon_variant | 4/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250856Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135670
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461306Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726960
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
Citrullinemia type I Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 04, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | May 03, 2018 | - - |
Citrullinemia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 27, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 528373). This premature translational stop signal has been observed in individual(s) with classical neonatal form of citrullinemia (PMID: 24889030). This variant is present in population databases (rs756859126, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Gln357*) in the ASS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASS1 are known to be pathogenic (PMID: 18473344, 19006241). - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 23, 2023 | Variant summary: ASS1 c.1069C>T (p.Gln357X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 250856 control chromosomes (gnomAD). c.1069C>T has been reported in the literature as a familial variant of a fetus at risk however this fetus did not appear to inherit the variant (Miller_2014). This report does not provide unequivocal conclusions about association of the variant with Citrullinemia Type I. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 24889030). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jul 30, 2017 | The c.1069C>T variant (rs756859126) has been previously reported in an unaffected carrier included in a study of pregnancies at risk for citrullinemia; however, the tested fetus was found not to carry any pathogenic variant and did not have biochemical findings consistent with citrullinemia (Miller 2014). Nonetheless, the c.1069C>T variant introduces an early termination codon into exon 14 (out of 16) in the ASS1 gene and is expected to result in a truncated or absent protein product. Consistent with a heterozygous carrier frequency, this variant is listed in the Genome Aggregation Database (gnomAD) browser with an overall frequency of 0.0004% (identified in 1 out of 245,770 chromosomes). Taken together, this variant is considered likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at